Build status - In Progress

Evaluating an Investigative Drug Letermovir (Prevymis) in Adults with Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV)

Recruiting
40 years - 99 years
All
15 participants needed
1 Location

Brief description of study

The purpose of this study is to test letermovir when given to people who have both well-controlled HIV infection and asymptomatic CMV infection. This study will also gather data on the effectiveness of letermovir to reduce inflammation when compared to no anti-CMV study treatment. In addition, the study will collect information on whether you experience any side effects from the study drug. The study will last for about 1 year and 2 months (about 11 months on either letermovir or no anti-CMV study treatment and then about another 3 months of follow-up). Compensation up to $825.

Detailed description of study

The purpose of this study is to test letermovir when given to people who have both well-controlled HIV infection and asymptomatic CMV infection. This study will also gather data on the effectiveness of letermovir to reduce inflammation when compared to no anti-CMV study treatment. In addition, the study will collect information on whether you experience any side effects from the study drug. The study will last for about 1 year and 2 months (about 11 months on either letermovir or no anti-CMV study treatment and then about another 3 months of follow-up). Compensation up to $825.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research,Human Immunodeficiency Virus,HIV-1,HIV,Asymptomatic Cytomegalovirus,CMV
  • Age: 40 years - 99 years
  • Gender: All

Participants Age 40+. Diagnosed with both HIV (the virus that causes AIDS) and a positive antibody test for cytomegalovirus (CMV) (a common virus that can infect almost anyone).

Updated on 04 Aug 2024. Study ID: 851174

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center